Europe Hydrogel-based Drug System Market By Polymer Origin (Synthetic, Natural and Hybrid), By Delivery Route (Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

The Europe Hydrogel-based Drug Delivery System Market would witness market growth of 7.6% CAGR during the forecast period (2021-2027).

Hydrogel-based drug delivery systems provide the therapeutic drug straight to the required site and in a sustainable manner. It can give beneficial results like minimize side effects, enhanced efficacy, and reduced dosage for patients & formulators. These hydrogel-based drug delivery systems are attracting several medical companies and have been utilized in numerous branches of medicine like pain management, oncology, cardiology, immunology, and wound management.

The growing prevalence of several diseases like CNS disorders is accelerating the demand for various therapies and thus, creating more demand for the hydrogel-based drug delivery systems in the European region. In addition, several companies are significantly investing in R&D to find out different medicines and treatments for different types of diseases.

Certain market players are majorly focusing on the optimization of hydrogel-based protein delivery, which would attract more customers towards it and hence, boosting the growth of the hydrogel-based drug delivery system market during the forecast period. The increasing investment of the authorities on various medical projects is surging the growth of the hydrogel-based drug delivery system market in the European region.

The Germany market dominated the Europe Oral Cavity Market by Country in 2020, thereby, achieving a market value of $83.7 Million by 2027. The UK market is exhibiting a CAGR of 6.8% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 8.1% during (2021 - 2027).

Based on Polymer Origin, the market is segmented into Synthetic, Natural and Hybrid. Based on Delivery Route, the market is segmented into Ocular, Subcutaneous, Oral Cavity, Topical and Other Delivery Routes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Hydrogel-based Drug System Market Size will Hit $9.3 Billion by 2027, at a CAGR of 8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Polymer Origin

• Synthetic
• Natural
• Hybrid

By Delivery Route

• Ocular
• Subcutaneous
• Oral Cavity
• Topical
• Other Delivery Routes

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Johnson & Johnson
• Bausch Health Companies, Inc.
• Medtronic PLC
• Galderma S.A.
• Endo International PLC
• Ferring Holdings SA
• Akorn Operating Company LLC
• Tolmar Pharmaceuticals, Inc.
• Blairex Laboratories, Inc.
• Ocular Therapeutix, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Hydrogel-based Drug System Market, by Polymer Origin
1.4.2 Europe Hydrogel-based Drug System Market, by Delivery Route
1.4.3 Europe Hydrogel-based Drug System Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Hydrogel-based Drug Delivery System Market by Polymer Origin
3.1 Europe Synthetic Market by Country
3.2 Europe Natural Market by Country
3.3 Europe Hybrid Market by Country

Chapter 4. Europe Hydrogel-based Drug Delivery System Market by Delivery Route
4.1 Europe Ocular Market by Country
4.2 Europe Subcutaneous Market by Country
4.3 Europe Oral Cavity Market by Country
4.4 Europe Topical Market by Country
4.5 Europe Other Delivery Routes Market by Country

Chapter 5. Europe Hydrogel-based Drug Delivery System Market by Country
5.1 Germany Hydrogel-based Drug Delivery System Market
5.1.1 Germany Hydrogel-based Drug Delivery System Market by Polymer Origin
5.1.2 Germany Hydrogel-based Drug Delivery System Market by Delivery Route
5.2 UK Hydrogel-based Drug Delivery System Market
5.2.1 UK Hydrogel-based Drug Delivery System Market by Polymer Origin
5.2.2 UK Hydrogel-based Drug Delivery System Market by Delivery Route
5.3 France Hydrogel-based Drug Delivery System Market
5.3.1 France Hydrogel-based Drug Delivery System Market by Polymer Origin
5.3.2 France Hydrogel-based Drug Delivery System Market by Delivery Route
5.4 Russia Hydrogel-based Drug Delivery System Market
5.4.1 Russia Hydrogel-based Drug Delivery System Market by Polymer Origin
5.4.2 Russia Hydrogel-based Drug Delivery System Market by Delivery Route
5.5 Spain Hydrogel-based Drug Delivery System Market
5.5.1 Spain Hydrogel-based Drug Delivery System Market by Polymer Origin
5.5.2 Spain Hydrogel-based Drug Delivery System Market by Delivery Route
5.6 Italy Hydrogel-based Drug Delivery System Market
5.6.1 Italy Hydrogel-based Drug Delivery System Market by Polymer Origin
5.6.2 Italy Hydrogel-based Drug Delivery System Market by Delivery Route
5.7 Rest of Europe Hydrogel-based Drug Delivery System Market
5.7.1 Rest of Europe Hydrogel-based Drug Delivery System Market by Polymer Origin
5.7.2 Rest of Europe Hydrogel-based Drug Delivery System Market by Delivery Route

Chapter 6. Company Profiles
6.1 Johnson & Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 Bausch Health Companies, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.3 Medtronic PLC
6.3.1 Company overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Galderma S.A.
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Partnerships, Collaborations, and Agreements:
6.4.2.2 Approvals & Trials:
6.5 Endo International PLC
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental Analysis
6.5.4 Research & Development Expenses
6.6 Ferring Holdings SA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research and Development Expense
6.7 Akorn Operating Company LLC
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Approvals & Trials:
6.8 Tolmar Pharmaceuticals, Inc.
6.8.1 Company Overview
6.9 Blairex Laboratories, Inc.
6.9.1 Company Overview
6.10. Ocular Therapeutix, Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Research & Development Expenses
6.10.4 Recent strategies and developments:
6.10.4.1 Partnerships, Collaborations, and Agreements:
6.10.4.2 Approvals & Trials:

TABLE 1 Europe Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 2 Europe Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 3 Europe Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 4 Europe Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 5 Europe Synthetic Market by Country, 2017 - 2020, USD Million
TABLE 6 Europe Synthetic Market by Country, 2021 - 2027, USD Million
TABLE 7 Europe Natural Market by Country, 2017 - 2020, USD Million
TABLE 8 Europe Natural Market by Country, 2021 - 2027, USD Million
TABLE 9 Europe Hybrid Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Hybrid Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 12 Europe Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 13 Europe Ocular Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Ocular Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe Subcutaneous Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Subcutaneous Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Oral Cavity Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Oral Cavity Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Topical Market by Country, 2017 - 2020, USD Million
TABLE 20 Europe Topical Market by Country, 2021 - 2027, USD Million
TABLE 21 Europe Other Delivery Routes Market by Country, 2017 - 2020, USD Million
TABLE 22 Europe Other Delivery Routes Market by Country, 2021 - 2027, USD Million
TABLE 23 Europe Hydrogel-based Drug Delivery System Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Hydrogel-based Drug Delivery System Market by Country, 2021 - 2027, USD Million
TABLE 25 Germany Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 26 Germany Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 27 Germany Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 28 Germany Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 29 Germany Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 30 Germany Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 31 UK Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 32 UK Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 33 UK Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 34 UK Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 35 UK Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 36 UK Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 37 France Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 38 France Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 39 France Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 40 France Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 41 France Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 42 France Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 43 Russia Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 44 Russia Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 45 Russia Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 46 Russia Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 47 Russia Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 48 Russia Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 49 Spain Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 50 Spain Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 51 Spain Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 52 Spain Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 53 Spain Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 54 Spain Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 55 Italy Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 56 Italy Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 57 Italy Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 58 Italy Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 59 Italy Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 60 Italy Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 61 Rest of Europe Hydrogel-based Drug Delivery System Market, 2017 - 2020, USD Million
TABLE 62 Rest of Europe Hydrogel-based Drug Delivery System Market, 2021 - 2027, USD Million
TABLE 63 Rest of Europe Hydrogel-based Drug Delivery System Market by Polymer Origin, 2017 - 2020, USD Million
TABLE 64 Rest of Europe Hydrogel-based Drug Delivery System Market by Polymer Origin, 2021 - 2027, USD Million
TABLE 65 Rest of Europe Hydrogel-based Drug Delivery System Market by Delivery Route, 2017 - 2020, USD Million
TABLE 66 Rest of Europe Hydrogel-based Drug Delivery System Market by Delivery Route, 2021 - 2027, USD Million
TABLE 67 Key information –Johnson & Johnson
TABLE 68 key information – Bausch Health Companies, Inc.
TABLE 69 Key Information – Medtronic PLC
TABLE 70 Key Information – Galderma S.A.
TABLE 71 key Information – Endo International PLC
TABLE 72 key information – Ferring Holdings SA
TABLE 73 Key information - Akorn Operating Company LLC
TABLE 74 Key Information – Tolmar Pharmaceuticals, Inc.
TABLE 75 Key Information – Blairex Laboratories, Inc.
TABLE 76 Key information - Ocular Therapeutix, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Bausch Health Companies, Inc.